Design, Synthesis and Evaluation of Novel Chloro- Oxime Derivatives for Neurodegenerative Diseases

Aijun Zhang,Pengfei Fu,Zaijun Zhang,Haiyun Chen,Pei Yu

2016-01-01

Abstract:Neurodegenerative disease is a fatal disease of the human nervous system, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis and related polyglutamine expansion diseases. The US FDA had approved several drugs to treat neurodegenerative diseases, however, almost none of them could delay progress of these diseases and offer cure. A key molecular pathway implicated in neurodegenerative diseases is the misfolding aggregation and accumulation of proteins in neurons. Chloro-oxime derivatives, such as bimoclomol and arimoclomol, promote the expression of heat shock proteins and improve the abilities of normal protein folding and degrade misfolded proteins. Based on the structure of bimoclomol and arimoclomol, we substituted the pyridine and piperazine by TMP and other amino groups, and synthesised a series of novel chloro-oxime derivatives. Among these chloro-oxime derivatives, compounds 9b and 13b were demonstrated to be neuroprotective against MG-132-induced neurotoxicity in SH-SY5Y cells.